Biotech Takes Innovative Approach To Raising Capital For
Published : 13-11-2023 - Duration : 09:24 - View : 6
Dailymotion : Download MP4 Convert to MP3
Description :
Dr. Vuong Trieu, CEO & Chairman of Oncotelic Therapeutics, Inc. was recently a guest on Benzinga’s All-Access.Oncotelic is a biotechnology company focused on developing RNA therapeutics for hard-to-treat cancers. The company has extensive experience in the field and its lead candidate OT-101 has shown very positive results in trials. Money in bio...

Related Videos :
This Biotech Is Creating Targeted Radiotherapuetics For Some Of The Deadliest Cancers. Hear From Plus Therapeutics At Benzinga's Virtual Healthcare Summit |
Gene Therapy Market to 2020 Moving Toward Commercialization |
Korea succeeds in developing its first light aircraft for commercialization |
DRESSED TO ILL: Internet Site Sells Ebola Containment Suit Halloween Costume. Funny, Offensive Or Genius Commercialization Of A Deadly Pandemic? |
Ophir Shaaf - Innovation, infrastructure & investment - Drivers of research commercialization |